Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.345
-0.165 (-10.93%)
May 14, 2026, 3:32 PM EDT - Market open
Neuronetics Employees
Neuronetics had 658 employees as of December 31, 2025. The number of employees decreased by 58 or -8.10% compared to the previous year.
Employees
658
Change (1Y)
-58
Growth (1Y)
-8.10%
Revenue / Employee
$230,450
Profits / Employee
-$56,403
Market Cap
93.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 658 | -58 | -8.10% |
| Dec 31, 2024 | 716 | 513 | 252.71% |
| Sep 30, 2024 | 201 | -10 | -4.74% |
| Jun 30, 2024 | 203 | -6 | -2.87% |
| Mar 31, 2024 | 202 | 2 | 1.00% |
| Dec 31, 2023 | 203 | 9 | 4.64% |
| Sep 30, 2023 | 211 | 13 | 6.57% |
| Jun 30, 2023 | 209 | 25 | 13.59% |
| Mar 31, 2023 | 200 | 13 | 6.95% |
| Dec 31, 2022 | 194 | 19 | 10.86% |
| Sep 30, 2022 | 198 | 33 | 20.00% |
| Jun 30, 2022 | 184 | 23 | 14.29% |
| Mar 31, 2022 | 187 | 40 | 27.21% |
| Dec 31, 2021 | 175 | 49 | 38.89% |
| Sep 30, 2021 | 165 | 43 | 35.25% |
| Jun 30, 2021 | 161 | 47 | 41.23% |
| Mar 31, 2021 | 147 | 30 | 25.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Outset Medical | 310 |
| AVITA Medical | 226 |
| Nano-X Imaging | 197 |
| Rapid Micro Biosystems | 171 |
| Xtant Medical Holdings | 151 |
| LENSAR | 150 |
| MaxCyte | 91 |
| Sera Prognostics | 72 |
STIM News
- 7 hours ago - Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment - GlobeNewsWire
- 9 days ago - Neuronetics reports Q1 EPS (16c), consensus (17c) - TheFly
- 9 days ago - Neuronetics backs FY26 revenue view $160M-$166M, consensus $162.47M - TheFly
- 9 days ago - Neuronetics Earnings Call Transcript: Q1 2026 - Transcripts
- 9 days ago - Neuronetics Reports First Quarter 2026 Financial and Operating Results - GlobeNewsWire
- 14 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call - GlobeNewsWire
- 4 weeks ago - Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners - GlobeNewsWire